Andy Mead

1.7k citations

33 papers · 1.3k indexed · h-index 23

Cellular and Molecular Neuroscience top 2%
- Neurotransmitter Receptor Influence on Behavior 23
- Neuroscience and Neuropharmacology Research 10
Behavioral Neuroscience top 10%
Toxicology top 5%
Biological Psychiatry top 10%
Cognitive Neuroscience top 5%
- Memory and Neural Mechanisms 5
Molecular Biology
- Receptor Mechanisms and Signaling 21
- Nicotinic Acetylcholine Receptors Study 3
Social Psychology
- Neuroendocrine regulation and behavior 7
Computational Theory and Mathematics
- Computational Drug Discovery Methods 2
Pharmacology
- Cannabis and Cannabinoid Research 2

Co-authors: David Stephens Eoin C. O’Connor Beatriz Rocha Kathryn Chapman Paul Butler Hans Rollema Barry E. Kosofsky Evan H Goulding
Cited by: Cellular and Molecular Neuroscience Behavioral Neuroscience Toxicology
Journals: Psychopharmacology (4 papers)Journal of Neuroscience (3 papers)European Journal of Neuroscience (3 papers)
Partner nations: United Kingdom United States Switzerland

In The Last Decade

Andy Mead

32 papers receiving 1.2k citations

Peers

Countries citing papers authored by Andy Mead

Since Specialization

Citations

This map shows the geographic impact of Andy Mead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Mead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Mead more than expected).

Fields of papers citing papers by Andy Mead

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Mead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Mead. The network helps show where Andy Mead may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andy Mead, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andy Mead Line = papers co-authored together Andy Mead links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Preclinical pharmacokinetics, metabolism, and disposition of NXE0041178, a novel orally bioavailable agonist of the GPR52 receptor with potential for treatment of schizophrenia and related psychiatric disorders Xenobiotica ·Hedro Lahdo,Nigel Austin,耕輝伊藤,祥史沢登,Alistair O’Brien,Ari Tolonen,小林利行,MoonSang Kwon,Andy Mead,G. Kallianpur	2025	0
2	The Identification of GPR52 Agonist HTL0041178, a Potential Therapy for Schizophrenia and Related Psychiatric Disorders ACS Medicinal Chemistry Letters ·Hedro Lahdo,Nigel Austin,Rachel Armstrong,Pascal van Lith,祥史沢登,Alícia P. Higueruelo,Joydeep Banerjee,Andy Mead,Richard F. Mould,G. Kallianpur,Alistair O’Brien,MoonSang Kwon,耕輝伊藤	2023	9
3	Translation of in vitro cannabinoid 1 receptor agonist activity to in vivo pharmacodynamic endpoints Journal of Pharmacological and Toxicological Methods ·Stephen Jenkinson,Arnis Febrianty,Adam Takeshita,Rhys Jones,Annie Otto‐Bruc,Soll C. Yates,Z. Wang,Paul Butler,Andy Mead	2020	1
4	Assessing the Value of the Zebrafish Conditioned Place Preference Model for Predicting Human Abuse Potential Journal of Pharmacology and Experimental Therapeutics ·Alistair J. Brock,Arnis Febrianty,Andy Mead,Ari Sudwarts,Matthew O. Parker,Caroline H. Brennan	2017	23
5	Assessing the predictive value of the rodent neurofunctional assessment for commonly reported adverse events in phase I clinical trials Regulatory Toxicology and Pharmacology ·Andy Mead,Hamid Amouzadeh,Kathryn Chapman,Lorna Ewart,Alessandra Giarola,Samuel J. Jackson,Philip Jarvis,Pierre J. Jordaan,Will S. Redfern,Martin Traebert,Jean‐Pierre Valentin,Hugo M. Vargas	2016	47
6	The Concordance between Nonclinical and Phase I Clinical Cardiovascular Assessment from a Cross-Company Data Sharing Initiative Toxicological Sciences ·Lorna Ewart,Mike Aylott,Mark Deurinck,Zuo Pengfei,David J. Gallacher,Helena Geys,Philip Jarvis,Haisong Ju,Derek J. Leishman,Rohit Gandhi,Nick McMahon,Andy Mead,Philip H. Milliken,Willi Suter,Ard Teisman,Karel Van Ammel,Hugo M. Vargas,Rob Wallis,Jean‐Pierre Valentin	2014	53
7	A translational pharmacology approach to understanding the predictive value of abuse potential assessments Behavioural Pharmacology ·Vasielios Kostakis,David M. Potter,Andy Mead	2013	40
8	Tramadol acts as a weak reinforcer in the rat self-administration model, consistent with its low abuse liability in humans Pharmacology Biochemistry and Behavior ·Eoin C. O’Connor,Andy Mead	2010	29
9	The mGluR5 Antagonist MTEP Dissociates the Acquisition of Predictive and Incentive Motivational Properties of Reward-Paired Stimuli in Mice Neuropsychopharmacology ·Eoin C. O’Connor,Hans S. Crombag,Andy Mead,David Stephens	2010	24
10	Effects of deletion of gria1 or gria2 genes encoding glutamatergic AMPA-receptor subunits on place preference conditioning in mice Psychopharmacology ·Andy Mead,Geraldine Brown,Julie Le Merrer,David Stephens	2004	44
11	Sensitization of Psychomotor Stimulation and Conditioned Reward in Mice: Differential Modulation by Contextual Learning Neuropsychopharmacology ·Andy Mead,Hans S. Crombag,Beatriz Rocha	2003	24
12	Studying the neurobiology of stimulant and alcohol abuse and dependence in genetically manipulated mice Behavioural Pharmacology ·David Stephens,Andy Mead,Tamzin L. Ripley	2002	17
13	Increased vulnerability to self-administer cocaine in mice prenatally exposed to cocaine Psychopharmacology ·Beatriz Rocha,Andy Mead,Barry E. Kosofsky	2002	54
14	Intravenous cocaine-induced activity in A/J and C57BL/6J mice: behavioral sensitization and conditioned activity Neuropharmacology ·Andy Mead,Jonathan L. Katz,Beatriz Rocha	2002	10
15	Intravenous cocaine induced‐activity and behavioural sensitization in norepinephrine‐, but not dopamine‐transporter knockout mice European Journal of Neuroscience ·Andy Mead,Beatriz Rocha,David M. Donovan,Jonathan L. Katz	2002	41
16	Previous experience of withdrawal from chronic diazepam ameliorates the aversiveness of precipitated withdrawal and reduces withdrawal‐induced c‐fos expression in nucleus accumbens European Journal of Neuroscience ·Yulia Virantina,Andy Mead,David Stephens	2000	17
17	AMPA‐receptor involvement in c‐fos expression in the medial prefrontal cortex and amygdala dissociates neural substrates of conditioned activity and conditioned reward European Journal of Neuroscience ·Andy Mead,Anna Vasilaki,Christina Spyraki,Theodora Duka,David Stephens	1999	52
18	AMPA involvement in c-fos expression in prefrontal cortex and amygdala dissociates neural substrates of conditioned activity and conditioned reward Andy Mead,Anna Vasilaki,Christina Spyraki,Theodora Duka,David Stephens	1999	2
19	AMPA-receptors are involved in the expression of amphetamine-induced behavioural sensitisation, but not in the expression of amphetamine-induced conditioned activity in mice Neuropharmacology ·Andy Mead,David Stephens	1998	43
20	AMPA receptors and motivation for drug: effect of the selective antagonist NBQX on behavioural sensitization and on self-administration in mice Behavioural Pharmacology ·Andrew Jackson,Andy Mead,Beatriz Rocha,David Stephens	1998	40

About Andy Mead

Andy Mead is a scholar working on Cellular and Molecular Neuroscience, Small Animals and Social Psychology, having authored 33 papers that have together received 1.3k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (23 papers), Receptor Mechanisms and Signaling (21 papers), Neuroscience and Neuropharmacology Research (10 papers), Neuroendocrine regulation and behavior (7 papers), Memory and Neural Mechanisms (5 papers), Nicotinic Acetylcholine Receptors Study (3 papers), Computational Drug Discovery Methods (2 papers) and Cannabis and Cannabinoid Research (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (940 citations), Behavioral Neuroscience (70 citations) and Toxicology (55 citations). Andy Mead has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include David Stephens, Eoin C. O’Connor, Beatriz Rocha, Kathryn Chapman, Paul Butler, Hans Rollema, Barry E. Kosofsky, Evan H Goulding, Loren H. Parsons and Nicole G. Coufal. Their work appears in journals such as Psychopharmacology, Journal of Neuroscience, European Journal of Neuroscience, Behavioural Pharmacology and Neuropsychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact